MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
2020 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
1.53 M |
Marktkapitalisierung |
$ 3.08 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Vertex Pharmaceuticals Incorporated
VRTX
|
$ 499.74 | 0.08 % | $ 128 B | Nasdaq Global Select Market,SPB | USA |
 |
Ascendis Pharma A/S
ASND
|
$ 225.25 | 0.42 % | $ 13.7 B | Nasdaq Global Select Market |  Danmark |
 |
Axon Enterprise
AXON
|
$ 390.29 | 2.15 % | $ 30.5 B | Nasdaq Global Select Market,SPB | USA |
 |
AbbVie
ABBV
|
$ 285.42 | 0.71 % | $ 505 B | NYSE,SPB | USA |
 |
Black Diamond Therapeutics
BDTX
|
$ 1.72 | 2.35 % | $ 97.8 M | Nasdaq Global Select Market,SPB | USA |
 |
Altimmune
ALT
|
$ 2.2 | 2.16 % | $ 194 M | Nasdaq Global Market | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
$ 4.22 | 2.39 % | $ 809 M | Nasdaq Global Select Market |  Canada |
 |
Oncternal Therapeutics
ONCT
|
- | -24.12 % | $ 1.56 M | Nasdaq Capital Market | USA |
 |
Catalyst Biosciences
CBIO
|
$ 11.84 | 0.87 % | $ 1.06 B | Nasdaq Capital Market | USA |
 |
Seagen
SGEN
|
- | - | $ 42.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Codexis
CDXS
|
$ 1.24 | 5.43 % | $ 108 M | Nasdaq Global Select Market | USA |
 |
Cullinan Management
CGEM
|
$ 12.93 | 2.64 % | $ 779 M | Nasdaq Global Select Market | USA |
 |
Compugen Ltd.
CGEN
|
$ 1.96 | 4.0 % | $ 183 M | Nasdaq Global Market,SPB |  Israel |
 |
Cellectar Biosciences
CLRB
|
$ 1.14 | 0.84 % | $ 2.97 M | Nasdaq Capital Market | USA |
 |
Amarin Corporation plc
AMRN
|
$ 11.32 | 0.17 % | $ 4.7 B | Nasdaq Global Market |  Irlanda |
 |
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
Cocrystal Pharma
COCP
|
$ 1.02 | 0.49 % | $ 11.5 M | Nasdaq Capital Market | USA |
 |
Aclaris Therapeutics
ACRS
|
$ 3.28 | 3.25 % | $ 402 M | Nasdaq Global Select Market | USA |
 |
Collegium Pharmaceutical
COLL
|
$ 23.19 | 0.04 % | $ 734 M | Nasdaq Global Select Market | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
$ 4.52 | 4.39 % | $ 60.2 M | Nasdaq Global Market | USA |
 |
Curis
CRIS
|
$ 0.41 | 1.4 % | $ 5.4 M | Nasdaq Global Market | USA |
 |
Corvus Pharmaceuticals
CRVS
|
$ 9.52 | 5.01 % | $ 752 M | Nasdaq Global Market | USA |
 |
Vascular Biogenics Ltd.
VBLT
|
- | -8.77 % | $ 12.4 M | Nasdaq Global Select Market | Israel |
 |
Berkeley Lights
BLI
|
- | -7.31 % | $ 87 M | Nasdaq Global Select Market | USA |
 |
Histogen
HSTO
|
- | 31.6 % | $ 2.12 M | Nasdaq Global Select Market | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
$ 24.02 | 0.39 % | $ 3.64 B | Nasdaq Global Select Market,SPB | USA |
 |
Denali Therapeutics
DNLI
|
$ 17.61 | 2.63 % | $ 3.04 B | Nasdaq Global Select Market,SPB | USA |
 |
Achieve Life Sciences
ACHV
|
$ 6.38 | 0.79 % | $ 278 M | Nasdaq Capital Market | USA |
 |
ImmunoGen
IMGN
|
- | - | $ 7.92 B | Nasdaq Global Select Market | USA |
 |
Precision BioSciences
DTIL
|
$ 5.77 | 2.32 % | $ 74 M | Nasdaq Global Select Market | USA |
 |
Editas Medicine
EDIT
|
$ 2.35 | 7.49 % | $ 209 M | Nasdaq Global Select Market,SPB | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
$ 84.95 | 0.13 % | $ 7.99 B | Nasdaq Global Select Market | USA |
 |
Agios Pharmaceuticals
AGIO
|
$ 31.32 | 4.36 % | $ 1.82 B | Nasdaq Global Select Market,SPB | USA |
 |
Enanta Pharmaceuticals
ENTA
|
$ 11.1 | 2.59 % | $ 237 K | Nasdaq Global Select Market,SPB | USA |
 |
Exelixis
EXEL
|
$ 62.23 | 0.06 % | $ 16.9 B | Nasdaq Global Select Market,SPB | USA |
 |
EyePoint Pharmaceuticals
EYPT
|
$ 2.99 | 4.32 % | $ 219 K | Nasdaq Global Market | USA |
 |
AIM ImmunoTech
AIM
|
$ 0.17 | 1.53 % | $ 275 K | NYSE American | USA |
 |
Cidara Therapeutics
CDTX
|
- | - | $ 1.41 B | Nasdaq Global Market | USA |
 |
Iterum Therapeutics
ITRM
|
- | - | $ 591 K | Nasdaq Global Select Market | Irlanda |
 |
Akebia Therapeutics
AKBA
|
$ 0.67 | 0.14 % | $ 172 M | Nasdaq Global Market | USA |
 |
GlaxoSmithKline plc
GSK
|
$ 49.51 | 1.0 % | $ 201 B | NYSE |  Britain |
 |
GT Biopharma
GTBP
|
$ 7.03 | 18.52 % | $ 38.8 M | Nasdaq Capital Market | USA |
 |
Heron Therapeutics
HRTX
|
$ 0.36 | 4.01 % | $ 60 M | Nasdaq Global Select Market,SPB | USA |
 |
Johnson & Johnson
JNJ
|
$ 255.56 | 0.86 % | $ 615 B | NYSE,SPB | USA |
 |
Akari Therapeutics, Plc
AKTX
|
$ 8.18 | 19.02 % | $ 551 B | Nasdaq Capital Market | Britain |
 |
Clovis Oncology
CLVS
|
- | -7.23 % | $ 13 M | Nasdaq Global Select Market | USA |
 |
Arcutis Biotherapeutics
ARQT
|
$ 28.82 | 10.19 % | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Aldeyra Therapeutics
ALDX
|
$ 0.7 | 0.62 % | $ 42 M | Nasdaq Global Select Market | USA |
 |
Kura Oncology
KURA
|
$ 9.08 | 0.94 % | $ 796 M | Nasdaq Global Select Market | USA |